Magle Chemoswed has been fatured in Dagens Industri as a part of the Almedalsveckan supplement. Click below to read the full article (in Swedish). Read more
About Gustaf Ström
This author has yet to write their bio.Meanwhile lets just say that we are proud Gustaf Ström contributed a whooping 6 entries.
Entries by Gustaf Ström
The Quality Management System of Magle Chemoswed har been transformed from a traditional GMP system to a bilingual system also addressing the requirements of ISO 13485:2016 for Medical devices. After passing a successful onsite audit the ISO 13485 certification was granted on April 28, 2019 by the Notified Body CE Certiso, NB 2409. The scope […]
As a part of the efforts to modernize, Magle Chemoswed has invested in new modular facilites to be placed on the production facility site. We are happy to announce that planning permission has been granted by Malmö Stad and that our move from the Celsiusgatan facilites will move forward as planned. The new facliites mean […]
Magle Chemoswed has received positive responses from regulatory agencies for market authorization of its range of advanced wound care products. This provides us with a clear pathway to registration of these developed products. As a strategic market for the Company this is an exciting and welcome development. The first line of products are expected to filed […]
Magle Chemoswed expands its sales of Benserazide to a key customer as part of the Company strategy to enter emerging markets. The sale of Benserazide is testament to our strong commitment to make a difference in the field of healthcare and responsibly expanding our business to new and exciting markets.
Magle Chemoswed has filed multi-jurisdictional patent applications for protection for our range of surgical diagnostic devices. This is a first-in-class invention under which we have chemically bound enzymatic indicators to our SmartSpheres to be used by surgeons following suturing to identify enzymatic leakage.